Schizophrenia study may aid treatment

By MALCOLM RITTER

AP Science Writer

NEW YORK

Scientists pursuing the biological roots of schizophrenia have zeroed in on a potential factor – a normal brain process that gets kicked into overdrive. The finding could someday lead to ways to treat the disease or even prevent it.

The result – accomplished by analysis of genetics, autopsy brain tissue and laboratory mice – is “going to be a game-changer” in terms of understanding schizophrenia and offering routes for treatment and potential for prevention, said Bruce Cuthbert, acting deputy director of the National Institute of Mental Health, which helped fund the research.

An expert unconnected to the research said the study’s conclusion was not yet proven, but plausible.

Almost 1 percent of the general population will have schizophrenia at some point in their lives. They may hear voices or hallucinate, talk about strange ideas, and believe others are reading their minds or plotting against them.

Nobody knows what causes the disorder, so the new result offers a possible peek into a black box.

The finding might pertain to “a very substantial fraction of cases, maybe most cases, even,” said senior author Steven McCarroll, of Harvard Medical School and the Broad Institute in Cambridge, Mass.

The result links schizophrenia risk to a problem with a normal process that happens in adolescence and early adulthood, when disease symptoms often appear. That age range is when the brain trims back the number of specialized places on brain cells where the cells signal each other, called synapses. The new work suggests a connection to schizophrenia when this process gets out of hand, deleting too many synapses.

The new work identified a risk gene and found evidence for the over-pruning idea.

Drawing on DNA data from 28,799 people with schizophrenia and 35,986 people without it, the researchers found that a gene called C4 can raise a person’s risk by about 30 percent over that of the general population.

The gene comes in several forms, and researchers examining brain tissue found evidence that the forms that pose the most risk of schizophrenia were also the most active in the brain. In lab mice, they found that the gene plays a key role in pruning synapses.

The study doesn’t directly demonstrate that that excessive pruning of synapses plays a role in schizophrenia, but the idea makes sense, McCarroll said. It ties together previous observations, among them that schizophrenia most often develops during youth and that patients’ brains show unusually few synapses, he said.

If it’s true, scientist can think about finding drugs that would intervene, McCarroll said. They might be useful to give when young people show symptoms that suggest they may be on the road to developing schizophrenia, he said. And even after the diagnosis, such drugs might keep the disease from getting worse, he said.

But any such treatments are years away, he cautioned.